BG-A3004
/ BeOne Medicines
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 20, 2026
A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases
(clinicaltrials.gov)
- P1 | N=98 | Recruiting | Sponsor: BeOne Medicines | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Dermatology
1 to 1
Of
1
Go to page
1